BC Cancer
BC Cancer
Vancouver, British Columbia, Canada6 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Preliminary Assessment of [18F]BL40 in PET/CT Scans | B-cell chronic lymphocytic leukemia, B-cell neoplasm, Blood Protein Disorders, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Lymphoma, B-Cell, Marginal Zone, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Waldenstrom macroglobulinemia, cardiovascular disorder, diffuse large B-cell lymphoma, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, marginal zone lymphoma, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Not stated | 2026-10-01 | NCT06224309 | |
| Evidence Development in Cancer Treatment - Real World: PREDiCTrw | cancer, neoplasm | Recruiting | Not applicable | 2025-09-25 | NCT06242912 | |
| PRecision Oncology Evidence Development in Cancer Treatment - Liquid | cancer, neoplasm | Active, not recruiting | Not applicable | 2025-09-25 | NCT05057234 | |
| PRecision Oncology Evidence Development in Cancer Treatment - Clinical: PREDiCTc | cancer, neoplasm | Recruiting | Not applicable | 2025-09-25 | NCT04814095 | |
| CSF Analysis in EGFR Mutant Non-Small Cell Lung Cancer With Leptomeningeal Disease | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, central nervous system cancer, lung disorder, lung neoplasm, neoplasm, neoplastic meningitis, nervous system disorder, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm, tumor of meninges | Recruiting | Not applicable | 2025-02-11 | NCT05257967 | |
| Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer | Breast Cancer Female; Hormone Receptor Positive Tumor | Active, not recruiting | Phase 2 | 2023-06-15 | NCT03917082 |